Marksans Pharma Ltd. (MARKSANS) Share Price Hits Fresh 52-Week High

Marksans Pharma Ltd. Share Price rose to Rs 341.95, up 2.69% today, after touching a fresh 52-week high of Rs 342.25. Market capitalisation stands at Rs 15,090.35 crore.

Marksans Pharma Ltd. Share Price climbed to Rs 341.95 on 17 August 2026, up Rs 8.95 or 2.69% from the previous close of Rs 333, and touched a fresh 52-week high of Rs 342.25 during the session. With a market capitalisation of Rs 15,090.35 crore, the move has placed the stock among closely watched names in Stock Market Today and the broader Indian Stock Market.

The verified data confirms a clear price event: Marksans Pharma Ltd. Share Price Today opened at Rs 336.65, traded between Rs 334 and Rs 342.25, and hit a new one-year high with turnover of Rs 5.96 crore and volume of 1,74,397 shares. The data confirms the price breakout to a yearly high, but it does not establish a company-specific catalyst behind the move.

For investors tracking Marksans Pharma Ltd. Stock News, the immediate relevance comes from the combination of fresh price strength and an unusual valuation profile. The stock trades on a P/E ratio of 184.72 and a P/B ratio of 0.45, while reported ROE is -2.89 and ROCE is -0.26. Univest notes that these figures make the stock worth monitoring not just for momentum, but also for how valuation and profitability compare with the wider Healthcare sector.

Marksans Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 341.95
Previous Close	Rs 333
Today's Change	+Rs 8.95 (+2.69%)
Day Open	Rs 336.65
Fresh 52-Week High	Rs 342.25
Day Low	Rs 334
Current Volume	1,74,397
Turnover	Rs 5.96 crore
Market Capitalisation	Rs 15,090.35 crore

Marksans Pharma Ltd. (MARKSANS) traded at Rs 341.95. versus the previous close of Rs 333, a rise of 2.69%. The stock opened at Rs 336.65, reached Rs 342.25, touched Rs 334. Reported volume was 1,74,397.

Marksans Pharma Ltd. Share Price Today registered a fresh 52-week high after opening above the previous close and extending gains through the session range. The move was backed by Rs 5.96 crore in turnover and 1,74,397 shares in volume, showing active participation as the stock approached its 52-week peak.

In pure price-action terms, Marksans Pharma Ltd. Share Price opened at Rs 336.65 against the previous close of Rs 333, indicating a positive start. It then moved between an intraday low of Rs 334 and an intraday high of Rs 342.25, which also became the new 52-week high. At Rs 341.95, the stock was holding close to the top of the day’s range, keeping the one-year high firmly in focus.

The day change of Rs 8.95 translates into a gain of 2.69%, which is meaningful for a company with a market cap of Rs 15,090.35 crore. The fact that the stock remained near its intraday high rather than sharply retreating suggests that the day’s upward move was sustained through the available trading window captured in the supplied data.

For readers searching Marksans Pharma Ltd. Share News or Marksans Pharma Ltd. Share Price Update, the main takeaway is straightforward: the stock marked a new yearly high at Rs 342.25 and was trading just below that level at Rs 341.95. That makes the current move notable in Market News, while the next step is to examine whether the supplied fundamentals support continued investor attention.

Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 15,090.35 crore
P/E Ratio	184.72x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Marksans Pharma Ltd. was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	184.72x
Benchmark Median P/E	21.1x
Benchmark Average P/E	49.38x
Benchmark P/E Range	0x to 1,603.4x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.71%
Company ROCE	-0.26%
Benchmark Median ROCE	13.15%
Company Market Capitalisation	Rs 15,090.35 crore
Benchmark Median Market Cap	Rs 135.27 crore

Marksans Pharma Ltd. (MARKSANS) is classified under sector: Healthcare.

Marksans Pharma Ltd. (MARKSANS) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Marksans Pharma Ltd. (MARKSANS) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Marksans Pharma Ltd. (MARKSANS) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	184.72	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	68.16	6.74	18.65	22.17
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	46.15	1.77	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,612.26	34.27	7.07	-2.6	16.92
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	58.41	8.73	11.42	13.15

Marksans Pharma Ltd. (MARKSANS) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Marksans Pharma Ltd. (MARKSANS) has a market capitalisation of Rs 15,090.35 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Marksans Pharma Ltd.

The stock is attracting attention because the price event is clear, while the underlying metrics create a more layered analytical picture. For investors following Stocks in News and 52 Week High Stocks, these are the key verified points.

• Fresh price milestone: Marksans Pharma Ltd. Share Price hit a new 52-week high of Rs 342.25 and was trading at Rs 341.95, up 2.69% on the day.
• Active trading session: The stock opened at Rs 336.65, moved between Rs 334 and Rs 342.25, and recorded turnover of Rs 5.96 crore with volume of 1,74,397 shares.
• Large market presence: Market capitalisation stands at Rs 15,090.35 crore, far above the sector benchmark median and average shown in the supplied dataset.
• Mixed valuation picture: The P/E ratio is 184.72, above the sector median of 21.1 and average of 49.38, while the P/B ratio of 0.45 is below the sector median of 1.9 and average of 2.3.
• Profitability gap: ROE of -2.89 and ROCE of -0.26 are below the Healthcare benchmark medians of 10.71 and 13.15 respectively.
• Peer positioning: Compared with selected Healthcare peers, the company is larger by market cap but trails several names on the supplied ROE and ROCE figures.

About Marksans Pharma Ltd.

Marksans Pharma Ltd. is a listed company tracked on the NSE under the symbol MARKSANS and classified in the Healthcare sector in the supplied dataset. In the context of today’s Marksans Pharma Ltd. Latest News, the company is in focus because its stock has touched a fresh one-year high.

The available verified data for this article primarily covers market behaviour and financial ratios rather than a detailed business profile. Based on the supplied classification, investors tracking Marksans Pharma Ltd. NSE activity are currently assessing the company through its share price movement, market capitalisation, sector benchmark positioning and peer comparison within Healthcare.

That makes today’s event less about a disclosed corporate development in the dataset and more about how the market is pricing the stock. For readers using Univest for Marksans Pharma Ltd. Share Price Live, the stock’s position at a fresh 52-week peak, alongside its valuation and return metrics, is the main reason it has become part of current Market Movers and stock updates.

Track Marksans Pharma Ltd. Share Price on Univest

Use Marksans Pharma Ltd. (MARKSANS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors using Univest can track Marksans Pharma Ltd. Share Price through live market data, 52-week levels, valuation ratios, sector context and peer comparison in one place. For a stock making a new 52-week high, that combination helps users follow both the immediate price move and the broader analytical backdrop.

Univest also helps readers monitor Marksans Pharma Ltd. Share Price Today alongside market cap, P/E, P/B, ROE, ROCE and related Healthcare comparisons. As this stock continues to feature in Marksans Pharma Ltd. Stock News and broader Share Market Today conversations, a structured dashboard can be useful for following verified market data without turning the event into a prediction.

Frequently Asked Questions

What is Marksans Pharma Ltd. Share Price today?

Ans. Marksans Pharma Ltd. Share Price today was Rs 341.95 at the time of the event capture. The stock was up Rs 8.95, or 2.69%, from the previous close of Rs 333 and remained close to its intraday high.

Why is Marksans Pharma Ltd. in focus today?

Ans. The stock is in focus because it touched a fresh 52-week high of Rs 342.25 on 17 August 2026. The available data confirms the price event, day gain, turnover and volume, but does not establish a company-specific catalyst.

What is the new 52-week high for Marksans Pharma Ltd.?

Ans. The new 52-week high for Marksans Pharma Ltd. is Rs 342.25. The stock traded at Rs 341.95 near that level after opening at Rs 336.65 and moving within an intraday range of Rs 334 to Rs 342.25.

How much did Marksans Pharma Ltd. rise today?

Ans. Marksans Pharma Ltd. rose by Rs 8.95 on the day, which translates into a gain of 2.69%. The move came from a previous close of Rs 333 to a current traded price of Rs 341.95.

What is the market capitalisation of Marksans Pharma Ltd.?

Ans. Marksans Pharma Ltd. has a market capitalisation of Rs 15,090.35 crore in the supplied data. That size is far above the Healthcare benchmark median of Rs 135.27 crore and average of Rs 456.49 crore.

Is Marksans Pharma Ltd. expensive on P/E compared with the Healthcare sector?

Ans. On the supplied numbers, Marksans Pharma Ltd. trades at a P/E ratio of 184.72. That is above the Healthcare sector median P/E of 21.1 and average of 49.38, placing it toward the higher end of the benchmark.

How does the P/B ratio of Marksans Pharma Ltd. compare with the sector?

Ans. Marksans Pharma Ltd. has a P/B ratio of 0.45 in the supplied dataset. This is below the Healthcare sector median P/B of 1.9 and average of 2.3, making its book-value multiple lower than the benchmark figures.

What do the ROE and ROCE figures show for Marksans Pharma Ltd.?

Ans. The supplied profitability metrics show ROE at -2.89 and ROCE at -0.26. Both are below the Healthcare benchmark medians of 10.71 for ROE and 13.15 for ROCE, indicating weaker reported return ratios.

Which peers are compared with Marksans Pharma Ltd. in this analysis?

Ans. The peer comparison in this article includes Dishman Carbogen Amcis, Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals. Marksans Pharma Ltd. has a larger market cap than each of these supplied peers.

Where can investors track Marksans Pharma Ltd. Share Price live?

Ans. Investors can track Marksans Pharma Ltd. Share Price live on Univest for market data, 52-week levels, valuation ratios and sector context. That helps place today’s one-year high alongside broader stock analysis and company metrics.